US Pharma MarketingThe U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.
AstraZeneca, GSK intensify China ties with Sino Biopharm deals
The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.
Source: BioPharma Dive